...
首页> 外文期刊>The Journal of Organic Chemistry >Synthesis of an Aminooxy Derivative of the Tetrasaccharide Repeating Unit of Streptococcus dysgalactiae 2023 Polysaccharide for a PS A1 Conjugate Vaccine
【24h】

Synthesis of an Aminooxy Derivative of the Tetrasaccharide Repeating Unit of Streptococcus dysgalactiae 2023 Polysaccharide for a PS A1 Conjugate Vaccine

机译:猪链球菌dysgalactiae 2023多糖四糖重复单元的氨基氧基衍生物的PS A1共轭疫苗的合成。

获取原文
获取原文并翻译 | 示例
           

摘要

A highly efficient and stereocontrolled synthesis of an aminooxy derivative of the tetrasaccharide repeating unit of a rhamnose-rich polysaccharide isolated from the cell envelop of bovine mastitis Streptococcus dysgalactiae 2023 is reported for the first time. The synthesis was accomplished utilizing a stereoselective and convergent [2 + 2] glycosylation strategy inclusive of a disaccharide Schmidt donor and an inclusive rhamnose disaccharide acceptor. The synthetic aminooxy tetrasaccharide was conjugated to T-cell stimulating immunogen PS Al from Bacteroides fragilis ATCC 25285/NCTC 9343-via a physiologically stable oxime linkage to furnish the first semisynthetic bacterial -based immunogen construct targeting S. dysgalactiae 2023. The synthetic tetrasaccharide was assembled in 19 steps with a similar to 5.0% overall yield.
机译:首次报道了从牛乳腺炎性痢疾链球菌2023细胞膜中分离的富含鼠李糖多糖的四糖重复单元的氨基糖衍生物的高效立体控制合成。利用立体选择性和会聚[2 + 2]糖基化策略(包括二糖施密特供体和囊状鼠李糖二糖受体)完成了合成。通过生理稳定的肟键,将合成的氨基氧基四糖与脆弱的拟杆菌(Bacteroides fragilis ATCC 25285 / NCTC 9343)的T细胞刺激性免疫原PS A1偶联,以提供第一个基于半合成细菌的免疫原构建体,以S. dysgalactiae 2023为目标。组装合成的四糖分19步进行,总收率接近5.0%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号